Corvus Pharmaceuticals, Inc.
CRVS$11.73▲ 1.12% 24h
Corvus Pharmaceuticals, Inc.CRVS$11.73
-$1.15(-8.92%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$985.27M
P/E ratio
—
EPS (diluted)
$-0.53
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-15.28M
Net margin
—
Gross margin
—
Dividends & financials
Corvus Pharmaceuticals, Inc. (CRVS) reported revenue of — and net income of $-15.28M, or $-0.53 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.